November 30, 2017
Novartis’ Cosentyx shows efficacy in nail and palmoplantar psoriasis
Novartis has announced first-of-its-kind long-term data showing that Cosentyx (secukinumab) provided sustained improvements in nail and palmoplantar psoriasis out to…